Cas 102768-06-9,DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid

102768-06-9

Post Buying Request

Basic information

Product Name: DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid
Synonyms: DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid
CAS NO:102768-06-9
Molecular Formula:
Molecular Weight: 390.523
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid(CAS DataBase Reference)
NIST Chemistry Reference: DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid(102768-06-9)
EPA Substance Registry System: DL-2-(3,4-dimethyl-benzoyl-amino)-5-(di-n-butyl-amino)-5-oxo-pentanoic acid(102768-06-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 102768-06-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

102768-06-9 Suppliers

Recommended suppliers

102768-06-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 102768-06-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,7,6 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 102768-06:
(8*1)+(7*0)+(6*2)+(5*7)+(4*6)+(3*8)+(2*0)+(1*6)=109
109 % 10 = 9
So 102768-06-9 is a valid CAS Registry Number.

102768-06-9Upstream product

102768-06-9Downstream Products

102768-06-9Relevant academic research and scientific papers

New glutamic and aspartic derivatives with potent CCK-antagonistic activity

Makovec,Chiste,Bani,et al.

, p. 9 - 20 (2007/10/02)

New derivatives of aspartic and glutamic acid were synthesized and evaluated in vitro and in vivo for anti-CCK activity on the guinea pig gallbladder. The anti-CCK activity of some 4-benzamido-glutaramic acid derivatives was a hundred times greater than that of proglutamide, the model compound, and they have been selected for further studies.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 102768-06-9